Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Personalis, Inc.(PSNL) | 14,044,943 | 14,044,943 | 0 | $91.57M | $111.80M | 40.47% | +$20.22M |
| Moderna, Inc.(MRNA) | 2,308,190 | 2,308,190 | 0 | $59.62M | $68.07M | 24.64% | +$8.45M |
| Kymera Therapeutics, Inc.(KYMR) | 772,165 | 772,165 | 0 | $43.70M | $60.08M | 21.75% | +$16.38M |
| Entrada Therapeutics, Inc.(TRDA) | 1,739,768 | 1,739,768 | 0 | $10.09M | $17.88M | 6.47% | +$7.79M |
| Evaxion Biotech A/sADS | 1,214,126 | 1,214,126 | 0 | $4.57M | $5.79M | 2.10% | +$1.23M |
| Alector Inc | 3,545,719 | 3,545,719 | 0 | $10.50M | $5.53M | 2.00% | -$4.96M |
| Sutro Biopharma, Inc.(STRO) | 2,723,509 | 272,351 | -2,451,158 | $2.37M | $3.15M | 1.14% | +$786.0K |
| Viridian Therapeutics, Inc.(VRDN) | 93,414 | 93,414 | 0 | $2.02M | $2.91M | 1.05% | +$891.2K |
| Xilio Therapeutics, Inc.(XLO) | 1,483,758 | 1,483,758 | 0 | $1.25M | $949.9K | 0.34% | -$300.5K |
| Carisma Therapeutics Inc | 1,473,240 | 1,473,240 | 0 | $403.7K | $63.3K | 0.02% | -$340.3K |
| Neuphoria Therapeutics Inc | 10,027 | 10,027 | 0 | $118.2K | $38.9K | 0.01% | -$79.3K |
| TuHURA Biosciences, Inc.(HURA) | 13,950 | 13,950 | 0 | $34.6K | $10.6K | 0.00% | -$24.0K |
| Lava Therapeutics NvSHS | 1,149,345 | 0 | -1,149,345 | $1.79M | $0 | — | -$1.79M |